Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Izotropic Corp (OP:IZOZF)

0.3465 +0.0652 (+23.18%)
Streaming Delayed Price Updated: 3:41 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Izotropic Corp

< Previous 1 2 3 Next >
TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) CEO Discusses IzoView Commercialization Strategy in New Departures Capital Interview
Via Investor Brand Network
Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
Via Investor Brand Network
Topics Artificial Intelligence
Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
EQNX::TICKER_START (OTCQB:IZOZF),(CSE:IZO),(NASDAQ:NVDA),(NYSE:BFLY),(NASDAQ:LNTH),(NASDAQ:RDNT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Breast Cancer Awareness Month by Addressing Gaps in Screening and Advancing the IzoView Breast CT Solution
Via Investor Brand Network
NetworkNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in NetworkNewsWire Editorial on AI-Driven 3D Imaging for Breast Cancer Detection
Via Investor Brand Network
Topics Artificial Intelligence
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
Via Investor Brand Network
Topics Artificial Intelligence Death
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
From Izotropic
Via GlobeNewswire
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
EQNX::TICKER_START (OTCQB:IZOZF),(CSE:IZO),(NASDAQ:HOLX),(NASDAQ:GEHC),(NASDAQ:NNOX),(NYSE:ORCL) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence Death
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Unveils IzoView: A Game-Changing Platform for Next-Gen Breast Cancer Detection
Via Investor Brand Network
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advances AI-Powered Breast CT Innovation and Reinforces Its Commitment to Safer, Smarter Cancer Imaging
Via Investor Brand Network
Topics Artificial Intelligence
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Expands Commercialization Strategy with $375K Financing, Investor Awareness Agreements, and Breakthrough Personalized Radiation Dose Breast CT
Via Investor Brand Network
TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Need for Advanced 3D Imaging During Breast Cancer Awareness Month
Via Investor Brand Network
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
From Izotropic
Via GlobeNewswire
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Anticipating Tomorrow’s Imaging Standards Today
Via Investor Brand Network
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights AI Role in Breast Imaging With New Feature Article
Via Investor Brand Network
Topics Artificial Intelligence
AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
From Izotropic
Via GlobeNewswire
TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Integrates Radiation Dose Personalization into IzoView Breast CT System
Via Investor Brand Network
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) CEO Featured in BMW Podcast Discussing Breakthrough Breast CT Imaging
Via Investor Brand Network
Topics Artificial Intelligence
Izotropic’s IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose
From Izotropic
Via GlobeNewswire
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Closes $375,000 Private Placement
Via Investor Brand Network
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches FAQ Page to Enhance Transparency and Investor Engagement
Via Investor Brand Network
Topics Artificial Intelligence
Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
From Izotropic
Via GlobeNewswire
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): When 15 Years of Data Creates Unassailable AI Advantage
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Exclusive CADx Patent Positions IzoView as First-Mover in AI-Enhanced Breast CT
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in MarketScreener Editorial on Targeted AI Applications
Via Investor Brand Network
Topics Artificial Intelligence
From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)
Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content 
Via News Direct
Topics Artificial Intelligence
From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)
Via AB Newswire
Topics Artificial Intelligence
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Advancing Dedicated Breast Imaging at a Market Crossroads
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) CEO Featured on IBN’s BioMedWire Podcast
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Secures Exclusive U.S. Patent for Computer-Aided Diagnosis with Breast CT
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.